Disodium Pamidronate
Overview
Disodium Pamidronate is a bisphosphonate, inhibits bone resorption and thus reduces bone turn over. Disodium Pamidronate is used in the treatment of bone disorders in which excessive bone resorption is a problem, such as paget`s disease of bone and osteoporosis. Disodium Pamidronate is also used as an adjunct insevere hypercalcaemic conditions especially associated with malignancies.
Categories
- 18 Hormones and other endocrine drugs and contraceptives
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Disodium Pamidronate's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 30 mg | 30 (30) | 24 hourly | IV | For paget disease: administered as a 4-hour infusion on 3 consecutive days for a total dose of 90 mg. |
| 60 to 90 mg | 75 (75) | As recommended. | IV | Moderate hypercalcemia: Given as a SINGLE-DOSE, intravenous infusion over 2 to 24 hours. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Disodium Pamidronate is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Disodium Pamidronate is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Disodium Pamidronate
Back to top
Manufacturers of
Disodium Pamidronate
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic